Early Detection of Adverse Drug Reaction Signals by Association Rule Mining Using Large-Scale Administrative Claims Data

被引:7
作者
Yamamoto, Hiroki [1 ]
Kayanuma, Gen [1 ]
Nagashima, Takuya [1 ]
Toda, Chihiro [1 ]
Nagayasu, Kazuki [1 ]
Kaneko, Shuji [1 ]
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Pharmacol, 46-29 Yoshida Shimoadachi Cho,Sakyo Ku, Kyoto 6068501, Japan
基金
日本学术振兴会;
关键词
SEQUENCE SYMMETRY ANALYSIS;
D O I
10.1007/s40264-023-01278-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
IntroductionAdverse drug reactions (ADRs) are a leading cause of mortality worldwide and should be detected promptly to reduce health risks to patients. A data-mining approach using large-scale medical records might be a useful method for the early detection of ADRs. Many studies have analyzed medical records to detect ADRs; however, most of them have focused on a narrow range of ADRs, limiting their usefulness.ObjectiveThis study aimed to identify methods for the early detection of a wide range of ADR signals.MethodsFirst, to evaluate the performance in signal detection of ADRs by data-mining, we attempted to create a gold standard based on clinical evidence. Second, association rule mining (ARM) was applied to patient symptoms and medications registered in claims data, followed by evaluating ADR signal detection performance.ResultsWe created a new gold standard consisting of 92 positive and 88 negative controls. In the assessment of ARM using claims data, the areas under the receiver-operating characteristic curve and the precision-recall curve were 0.80 and 0.83, respectively. If the detection criteria were defined as lift > 1, conviction > 1, and p-value < 0.05, ARM could identify 156 signals, of which 90 were true positive controls (sensitivity: 0.98, specificity: 0.25). Evaluation of the capability of ARM with short periods of data revealed that ARM could detect a greater number of positive controls than the conventional analysis method.ConclusionsARM of claims data may be effective in the early detection of a wide range of ADR signals.
引用
收藏
页码:371 / 389
页数:19
相关论文
共 46 条
  • [1] Increased risk of mycotic infections associated with sodium-glucose co-transporter 2 inhibitors: a prescription sequence symmetry analysis
    Adimadhyam, Sruthi
    Schumock, Glen T.
    Calip, Gregory S.
    Marsh, Daphne E. Smith
    Layden, Brian T.
    Lee, Todd A.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (01) : 160 - 168
  • [2] Agrawal R., 1994, P 20 INT C VER LARG, V1215, P487
  • [3] The lag-time approach improved drug-outcome association estimates in presence of protopathic bias
    Arfe, Andrea
    Corrao, Giovanni
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2016, 78 : 101 - 107
  • [4] A curated and standardized adverse drug event resource to accelerate drug safety research
    Banda, Juan M.
    Evans, Lee
    Vanguri, Rami S.
    Tatonetti, Nicholas P.
    Ryan, Patrick B.
    Shah, Nigam H.
    [J]. SCIENTIFIC DATA, 2016, 3
  • [5] Mining Directional Drug Interaction Effects on Myopathy Using the FAERS Database
    Chasioti, Danai
    Yao, Xiaohui
    Zhang, Pengyue
    Lerner, Samuel
    Quinney, Sara K.
    Ning, Xia
    Li, Lang
    Shen, Li
    [J]. IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS, 2019, 23 (05) : 2156 - 2163
  • [6] A Reference Standard for Evaluation of Methods for Drug Safety Signal Detection Using Electronic Healthcare Record Databases
    Coloma, Preciosa M.
    Avillach, Paul
    Salvo, Francesco
    Schuemie, Martijn J.
    Ferrajolo, Carmen
    Pariente, Antoine
    Fourrier-Reglat, Annie
    Molokhia, Mariam
    Patadia, Vaishali
    van der Lei, Johan
    Sturkenboom, Miriam
    Trifiro, Gianluca
    [J]. DRUG SAFETY, 2013, 36 (01) : 13 - 23
  • [7] Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010
    Downing, Nicholas S.
    Shah, Nilay D.
    Aminawung, Jenerius A.
    Pease, Alison M.
    Zeitoun, Jean-David
    Krumholz, Harlan M.
    Ross, Joseph S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (18): : 1854 - 1863
  • [8] FDA, 2018, PREV ADV DRUG REACT
  • [9] A Pharmacovigilance Approach for Post-Marketing in Japan Using the Japanese Adverse Drug Event Report (JADER) Database and Association Analysis
    Fujiwara, Masakazu
    Kawasaki, Yohei
    Yamada, Hiroshi
    [J]. PLOS ONE, 2016, 11 (04):
  • [10] Development and Inter-Rater Reliability of the Liverpool Adverse Drug Reaction Causality Assessment Tool
    Gallagher, Ruairi M.
    Kirkham, Jamie J.
    Mason, Jennifer R.
    Bird, Kim A.
    Williamson, Paula R.
    Nunn, Anthony J.
    Turner, Mark A.
    Smyth, Rosalind L.
    Pirmohamed, Munir
    [J]. PLOS ONE, 2011, 6 (12):